SNY Stock Chart





Fundamentals SNY

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Cash Ratio, FY ---
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---
AlexanderHamilton AlexanderHamilton SNY, D, Short ,
SNY: Sanofi potential short?
7 0 4
SNY, D Short
Sanofi potential short?

Not confident in this one. not much to make a decision on other than maybe momentum switch and bull trend needs to end.

bhowe bhowe IBB, W, Long ,
IBB: IBB Biotechnology sector
159 0 2
IBB, W Long
IBB Biotechnology sector

IBB, the tracking stock for the Bio sector looks ready to regain its upward trajectory. With the RSI and %R at very oversold positions it may be ready. We recently had a bounce off the 200ma, There appears to be consolidation in the blue box currently. Look for a move above the 8ema to enter long.

WholeLottaBull WholeLottaBull PIRS, D, Long ,
PIRS: Time to go long on PIRS, very long.
76 0 1
PIRS, D Long
Time to go long on PIRS, very long.

The has been absolutely no fundamental change to this bio company that has multiple big pharma partners. Yet due to the overall biotech downturn NASDAQ:PIRS was hit pretty hard. This presents a true 10 bagger opportunity, and Im not even remotely stretching the truth. The technicals show you why right now is the PERFECT time to buy. A little due diligence will ...

YoungMula YoungMula SNY, D, Short ,
SNY: Potential Break Down ?
14 0 0
SNY, D Short
Potential Break Down ?

Target $36.50

YoungMula YoungMula SNY, W,
SNY: Potential Short?
15 0 1
Potential Short?

Short on a break of the uptrend line

Elemental Elemental AMGN, D, Long ,
AMGN: Repatha will bring major volume and take AMGN to new heights.
233 4 1
AMGN, D Long
Repatha will bring major volume and take AMGN to new heights.

Repatha (AMGN) and Praluent (Regeneron (REGN)/Sinofy (SNY)) are two PCSK9 inhibitors, a new class of drugs to treat hypercholesterolemia more effectively than previously possible. This will trigger a HCV-like battle between the two as both have high efficacy. Both have room to share the market, allowing both to make a significant amount of money on these ...

daytraderrockstar daytraderrockstar PRO SNI, D, Long ,
SNI: $SNI is now 68.35. Price Target Hit. Great Hps Trade
64 0 0
SNI, D Long
$SNI is now 68.35. Price Target Hit. Great Hps Trade

$SNI is now 68.35. Price Target Hit. Great Hps (High Probablity Setup ) Trade.

jangseohee jangseohee EFA, W,
EFA: EFA, please do not break the neckline again!!!
86 3 7
EFA, please do not break the neckline again!!!

The iShares MSCI EAFE ETF seeks to track the investment results of an index composed of large- and mid-capitalization developed market equities, excluding the U.S. and Canada. Top then holdings are Nestle (switzerland), Novartis (switzerland), Roche (switzerland), HSBC (UK), Toyota (Jpn), Shell (UK), Bayer AG (Germany), BP (UK), Commonwealth Bank of Australia & ...

Verticalmojo Verticalmojo MNKD, D, Long ,
267 0 2
MNKD, D Long

Trend continuation, possible bullish outlook as long as price can stay above channel. MNKD (with partner Sanofi) is about to market and distribute FDA approved Afrezza, a inhaled insulin that can make insulin syringes a thing of the past. With diabetes a global condition that effects 371 million people worldwide and is expected to affect 552 million by 2030, ...

Wanna_Million Wanna_Million UNIS, D, Long ,
UNIS: UNIS - Reversal - Is this the start of a meaningful uptrend?
131 0 0
UNIS, D Long
UNIS - Reversal - Is this the start of a meaningful uptrend?

Unilife recently announced an agreement with Sanofi to be the sole provider for a minimum of 15 years of cartridge based wearable injectors for all of Sanofi’s large dose volume drugs, excluding insulin. While the details are confidential, it is anticipated that it is for a "fast track" drug for high cholesterol, Alirocumab, which is co- developed by Sanofi and ...

Jakeccc Jakeccc REGN, D, Long ,
REGN: If you've been waiting to get long REGN, now is the time.
46 0 2
REGN, D Long
If you've been waiting to get long REGN, now is the time.

It got beaten so badly because of some analyst's note saying that REGN's blockbuster eye drug Eylea has been replaced by cheaper rival drugs. First, it was only rumored to be "10%" of total patients, secondly, its rheumatoid arthritis drug "sarilumab" that is under development with Sanofi is showing promising signs and is now in phase 3. Overall, reaction is a ...

Jakeccc Jakeccc REGN, W, Long ,
REGN: Regeneron Long-term Trend Remains Intact.
55 0 1
REGN, W Long
Regeneron Long-term Trend Remains Intact.

Many sector leaders like Gilead, Celgene, and Biogen all had a nice run up at the end of the week, which is encouraging given people tend to sell on Friday, especially in this market. This bad boy went berserk in April 2013, flied away from this trend line and entered into a channel, which by the way, it broke exactly one year later, April 2014. Since then ...

BEI BEI SNY, M, Short ,
SNY: SNY update
96 0 0
SNY, M Short
SNY update

Still the same from previous post,, that's the problem with SNY, so slow it's not always attractive. Supports should make - 65 / 66 in 10 dollars prices swings

daytraderrockstar daytraderrockstar PRO SNY, D, Long ,
SNY: The most basic Pattern to Learn 1-2-3 Pattern
769 3 3
SNY, D Long
The most basic Pattern to Learn 1-2-3 Pattern

This is the foundation to many set ups. just like in anything you want to be great in you learn the basics and fundamentals. And great foundation will pay off

David_CMT_CFA David_CMT_CFA SNY, D, Long ,
150 0 0
SNY, D Long
Long SNY

Big euro pharma Fibo confluence Indicators confirm Upside to 60ish

Ideas Scripts Chart
United States
United Kingdom
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out